Company Overview
Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry in the United States, China, Korea, Europe, and the Asia Pacific. The company offers Hawk, a platform engineered for advanced packaging; Eagle G5 for enhanced detection and metrology; Eagle-i/Plus, a system that delivers 2D inspection and metrology capabilities; Eagle-AP/Plus, which addresses the advanced packaging market using software and hardware technologies that deliver 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle for the inspection and metrology of standard panel sizes. It also develops MicroProf AP, a wafer metrology tool for applications at 3D packaging process steps; MicroProf DI, an optical inspection tool that enables inspection of structured and unstructured wafers; MicroProf FE, a 2D/3D wafer metrology tool; MicroProf FS, a wafer metrology tool configurable; MicroProf PT for hybrid metrology applications to common panel sizes; MicroProf MHU metrology tool, a material handling unit for the semiconductor, MEMS, sapphire, and LED industries; MicroProf TL, an optical surface measurement tool for fully automatic 3D surface measurements; MicroProf 200, a measuring device for contactless and non-destructive characterization of surfaces and films; and MicroProf 300, a SurfaceSens technology for quality assurance, development, and manufacturing. The company serves semiconductor manufacturers, outsourced semiconductor assembly and test, integrated device manufacturers, and wafer level packaging subcontractors. Camtek Ltd. was incorporated in 1987 and is headquartered in Migdal HaEmek, Israel.
Why Investors Should Care
Revenue has grown at a 15.6% CAGR over the past five years.
Operating margin of 22.4% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $496.07M (+15.6% YoY); net profit $50.72M.
- Trailing 12 Months Year-on-year growth — revenue +2.5%, earnings -10.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 15.6%, profit CAGR -14.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 15.63% |
| 1 Year: | 2.50% |
Compounded Profit Growth
| 5 Years: | -14.07% |
| 1 Year: | -10.00% |
Stock Price Performance
| 1 Year: | +66.81% |
| 6 Months: | -5.30% |
| 3 Months: | -12.84% |
| 1 Month: | -5.37% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- Death Cross6d ago
- RSI (14)50.47 · Neutral
P/E of 198.66 is above the sector median of 29.22 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 15.6% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 198.7.
- Earnings shrank at -14.1% CAGR over 5 years.
- Trading 29.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CAMT Camtek Ltd. TECHAI | 147.01 | 198.66 | $6.86B | 0.00% | 11.12% | 7.56% | 15.63% | -14.07% |
| 2 | NVDA NVIDIA Corporation NDXSPXR3KAITECH | 225.73 | 28.50 | $5.45T | 0.46% | 74.66% | 117.21% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPXR3KTECH | 316.22 | 36.22 | $4.61T | 0.34% | 68.72% | 148.75% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXR3KAITECH | 493.95 | 27.49 | $3.67T | 0.79% | 26.33% | 34.04% | 9.93% | 11.90% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AITECH | 439.00 | 32.71 | $2.28T | 0.95% | 30.20% | 39.97% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXR3KAITECH | 368.56 | 46.95 | $1.75T | 0.71% | 16.70% | 44.25% | 17.04% | 54.08% |
| 7 | MU Micron Technology, Inc. NDXSPXR3KAITECH | 1,000.26 | 22.59 | $1.13T | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH | 505.74 | 128.36 | $825.61B | 0.00% | 5.47% | 10.20% | 11.81% | 66.28% |
| 9 | ASML ASML Holding N.V. NDXAITECH | 1,764.85 | 59.89 | $677.88B | 0.51% | 42.97% | 53.94% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 118.64M | 123.32M | 125.99M | 128.12M | 121.66M |
| Cost of Revenue | 58.07M | 60.71M | 62.95M | 64.02M | 60.73M |
| Gross Profit | 60.56M | 62.61M | 63.04M | 64.10M | 60.93M |
| Operating Expenses | 27.86M | 30.64M | 31.20M | 32.42M | 33.66M |
| Operating Income | 32.70M | 31.97M | 31.84M | 31.68M | 27.27M |
| EBITDA | 32.70M | 42.90M | 31.84M | -42.53M | 27.27M |
| Interest Expense | - | - | - | - | - |
| Pretax Income | 38.13M | 36.92M | -62.56M | 39.85M | 35.41M |
| Tax Provision | 3.82M | 3.22M | -9.38M | 3.95M | 3.77M |
| Net Income | 34.31M | 33.70M | -53.18M | 35.90M | 31.64M |
| Diluted EPS | 0.70 | 0.69 | -1.16 | 0.71 | 0.63 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 320.91M | 315.38M | 429.23M | 496.07M |
| Cost of Revenue | - | 161.05M | 167.74M | 219.28M | 245.75M |
| Gross Profit | - | 159.86M | 147.63M | 209.95M | 250.32M |
| Operating Expenses | - | 78.36M | 82.22M | 101.88M | 122.11M |
| Operating Income | - | 81.50M | 65.41M | 108.07M | 128.20M |
| EBITDA | - | 93.38M | 94.51M | 143.00M | 65.77M |
| Interest Expense | - | 1.09M | 1.09M | 1.09M | 1.66M |
| Pretax Income | - | 88.19M | 87.63M | 131.24M | 52.34M |
| Tax Provision | - | 8.24M | 9.00M | 12.72M | 1.61M |
| Net Income | - | 79.95M | 78.63M | 118.52M | 50.72M |
| Diluted EPS | - | 1.66 | 1.61 | 2.42 | 1.04 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 677.09M | 787.67M | 892.04M | 1.26B |
| Current Assets | - | 556.96M | 546.79M | 620.06M | 897.00M |
| Cash & Equivalents | - | 148.16M | 119.97M | 126.22M | 177.85M |
| Inventory | - | 65.54M | 85.91M | 111.20M | 112.20M |
| Receivables | - | 80.61M | 87.30M | 99.47M | 90.83M |
| Total Liabilities | - | 292.99M | 311.52M | 342.81M | 642.83M |
| Current Liabilities | - | 88.50M | 96.67M | 123.91M | 107.42M |
| Long Term Debt | - | 195.74M | 196.83M | 197.93M | 519.83M |
| Total Debt | - | 199.44M | 201.15M | 207.07M | 530.79M |
| Total Equity | - | 384.10M | 476.15M | 549.24M | 617.00M |
| Shares Outstanding | - | 46.51M | 46.99M | 47.54M | 47.92M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 57.80M | 79.32M | 122.24M | 141.87M |
| Investing Cash Flow | - | -150.79M | -107.45M | -55.91M | -310.32M |
| Financing Cash Flow | - | 3.00K | 182.00K | -60.05M | 218.99M |
| Capital Expenditure | - | -8.29M | -8.27M | -10.36M | -14.80M |
| Free Cash Flow | - | 49.51M | 71.05M | 111.88M | 127.07M |
| Net Change in Cash | - | -92.99M | -27.95M | 6.28M | 50.53M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 49.8% | 46.8% | 48.9% | 50.5% |
| Operating Margin % | - | 25.4% | 20.7% | 25.2% | 25.8% |
| Net Margin % | - | 24.9% | 24.9% | 27.6% | 10.2% |
| ROE % | - | 20.8% | 16.5% | 21.6% | 8.2% |
| ROCE % | - | 13.8% | 9.5% | 14.1% | 11.1% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Migdal Insurance & Financial Holdings Ltd. | 5.68% | 2.65M | $394.93M |
| 2 | Harel Insurance Investments & Financial Services Ltd. | 4.77% | 2.23M | $331.88M |
| 3 | Wasatch Advisors LP | 4.55% | 2.12M | $316.42M |
| 4 | Menora Mivtachim Holdings Ltd. | 4.50% | 2.10M | $313.03M |
| 5 | Clal Insurance Enterprises Holdings Ltd | 4.04% | 1.88M | $280.96M |
| 6 | Jane Street Group, LLC | 1.92% | 895.03K | $133.47M |
| 7 | Vanguard Capital Management LLC | 1.74% | 810.72K | $120.89M |
| 8 | Y.D. More Investments Ltd | 1.71% | 796.74K | $118.81M |
| 9 | Federated Hermes, Inc. | 0.98% | 459.00K | $68.45M |
| 10 | Goldman Sachs Group Inc | 0.66% | 307.91K | $45.92M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CAMT
Camtek Stock Price Forecast. Should You Buy CAMT? - StockInvest.us
<a href="https://news.google.com/rss/articles/CBMiSEFVX3lxTE9KVlZDSEJHMl9fMGFxazlERmlBVmVkREE3TWtGaE83cWJad3lzbk1ocE4yblFSNWVtcXZJNnhzZHVPSnUtMmNUYg?oc=5" target="_blank">Camtek Stock Price Forecast. Should You Buy CAMT?</a> <fon…
Camtek (CAMT) Stock Moves -8.35%: What You Should Know - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPQi1zcVlHS0FZZnlWcEpIbUxYdmtJY05JME16OE9KZ1B2d3hFV19KMEhtMDYyQ05XeXhxZlFvM3RzU3pWeU0wODJ0VHNkaU9WOGdFRmRJX2FsMU9QZVJ4eThKRkRscjQtS2N0QWVHVWFkQlIzZUNUT2lPM0dkMGVYbWt2bUl5WFNKSDBXVj…
Camtek (CAMT) Stock May Be Overvalued As AI Demand Expectations Build - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxNRmkxd19ZaHNobmQtSmxpOHJrX2RyNmhUS21lU3ZVazN5bWIwdGZnWGJmT2VMdldQcG9KOVZsbWNwY0RSUHZDNUJzSFVpb1dBQ1M3YkYzb1RGRlU0WTdpZlFrUk1paGxJMXp4bkVObmVOZGZqQ3ZFVlpqZ3lZeXdpYTB6UlBEYWVUMHhXUT…
$CAMT stock is down 10% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPbVdiSkRzUTB5c2RYT003eXhqcFloQVJXcnlCbk5YQV9aUWRNR2czT3AzSGt3NG1GcDVycW10N0xUOV9XQVBIRkt5dnhzeE9ZZ1l0ZF9IbE5ic2ZteDhhcVptLXBVcmFUanBXMmQ3NzVLUXFXTnhvZ2hoNUxCQ0hreVQyX011T0tyTUpmRm…
Implied Volatility Surging for Camtek Stock Options - tradingview.com
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQWFsVlVIRHh0LXFoUEg4YzlRME9TUGFSOWFncEVsNlVrcVpMLThSc0diUFFZempzUEtySWxnNklRRFhYTHJ0MDRuVVROSlFkcUIyYWl2SUwtdFRBVDY1OVd3b2JUM1ZjVW9VOXR5RXM0Y19wcV9KT2FSaDlmNWEtRW9JVzJ6cXFUMXRMal…
Camtek Ltd (CAMT) Shares Surge 5.3% -- What GF Score of 96 Tells Investors - gurufocus.com
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQQ05EQ0h1dHZ5NWw3d3ljNUpsODZ5ZV9ZaWNuaWZRcGVhV2tOVUxPRTd1VVRSVnNsVzZjWEUtWmxhdGRZOHlOVEtFMFg1MU5EWVVCVUVGWmlsVW96SXhSWWxDRVlxTUtELUtabUlMdWp3Z2p4WXhFc1lLamZYemJpRlpkNkVVM1llNzBDWU…
CAMT — Frequently Asked Questions
What is the current share price of Camtek Ltd. (CAMT)?
As of 2026-09-19 21:16 PDT, Camtek Ltd. (CAMT) trades at $147.01 on NasdaqGM. Its 52-week range is $76.73 to $207.46.
What is the market capitalisation of CAMT?
Camtek Ltd. (CAMT) has a market capitalisation of $6.86B on NasdaqGM.
What is the P/E ratio of CAMT?
CAMT trades at a trailing price-to-earnings (P/E) ratio of 198.66. The industry average P/E is 29.22. Its price-to-book (P/B) ratio is 11.04.
What is the return on equity (ROE) of CAMT?
CAMT has a return on equity (ROE) of 7.56%. Its return on capital employed (ROCE) is 11.12%.
Is CAMT a good stock to buy?
This page provides a data-driven analysis of Camtek Ltd. (CAMT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.